ArticleCancer medicine2026
Descriptive Epidemiology and Prognosis of Pediatric Acute Leukemia in the Afro-Descendant Population of the French West Indies and French Guiana.
Article in Cancer medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe epidemiology of acute leukemia (AL) in children in Afro-descendant (AD) populations is poorly described, and survival is often considered worse in these populations. The aim of this study is to describe the epidemiology and prognosis of childhood AL in the AD population of the French West Indies/French Guiana (FWI/FG).
methodsThis is a multicenter, retrospective, descriptive cohort study of children aged 0-17 years old, resident of the FWI/FG and diagnosed with AL between January 2010 and December 2022. Patients were identified via the French National Childhood Cancer Registry and cross-referenced with lists from each reference center and local registry. The Kaplan-Meier method was used to estimate 5-year overall survival (5y-OS) and event-free survival (5y-EFS).
resultsA total of 107 patients were included, 67% B-Acute lymphoblastic leukemia (ALL), 18% AML, and 14% T-ALL. The age standardized incidence rate for childhood AL was 32.9 (21.4-46.2) per million-year for children. The 5y-OS rate for all children was 90.9% (95% CI: 84.1-98.2), and 93.1% (95% CI: 85.8-100) for B-ALL, 91.7% (95% CI: 77.3%-100%) for T-ALL and 83.1% (95% CI: 64.1%-100%) for AML. The 5y-EFS were respectively 75.8% (95% CI: 66.3-86.5), 78.3% (95% CI: 67.6-90.8) and 83.9% (95% CI: 65.7-100) for all children, B-ALL and T-ALL. Seven patients (7%) died, mostly due to disease progression (57%).
conclusionThis is the largest epidemiological study reported on childhood AL in an AD population and in the Caribbean/Latin America zone. Survival rates in our AD population were similar to those described in European and North American studies and much better than in the Caribbean and Latin American zone.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.